Close
ACHEMA MIDDLE EAST 2026

WHO Body Recommends Vaccines To Be Updated For Variants

The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be...

To Scale Up Quantum Drug Discovery, Oxford Joins Consortium

SEEQC, which is a digital quantum computing company, and Oxford University have partnered to ensure accelerated use of computing based on the quantum method...

COVID-19 Impact On Changing Pharma Research And Development

Although we cannot say that it was unheard of, collaboration on the basis of interdisciplinary and interprofessional elements has always been crucial in any...

Amidst The Surge, Deltacron Variant Crops-Up In Cyprus

As per the Bloomberg News report on Saturday, January 8, Leondios Kostrikis, who is a professor in biological sciences at the University of Cyprus,...

Merck Steps Up Its Battle Against Maternal Mortality

A startling figure indeed when we say that around the globe, a lady dies every 2 minutes, due to complications arising from childbirth and...

Israel PM Says Second Booster Swells Antibodies Five Times

According to Naftali Bennett, the Israeli Prime Minister, as per preliminary findings in an Israeli study, a fourth COVID-19 jab can shoot-up antibodies five...

Autism clinical trials now open on the TrialWire Platform

TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. More than 6 million people have used...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...